CN Stock MarketDetailed Quotes

300841 Chengdu Kanghua Biological Products

Watchlist
  • 51.78
  • -0.82-1.56%
Market Closed Jan 3 15:00 CST
6.88BMarket Cap12.60P/E (TTM)

Chengdu Kanghua Biological Products Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q9)Sep 30, 2024
(Q6)Jun 30, 2024
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
Total operating revenue
7.10%1.06B
16.81%741.08M
11.96%311.37M
9.03%1.58B
-6.12%990.06M
-3.84%634.44M
4.27%278.11M
11.94%1.45B
35.23%1.05B
19.53%659.77M
Operating revenue
7.10%1.06B
16.81%741.08M
11.96%311.37M
9.03%1.58B
-6.12%990.06M
-3.84%634.44M
4.27%278.11M
11.94%1.45B
35.23%1.05B
19.53%659.77M
Other operating revenue
----
3,747,465.37%106.24M
----
-99.11%2.84K
----
--2.84K
----
--318.58K
----
--0
Total operating cost
-1.54%577.2M
0.60%365.39M
-19.05%134.86M
22.80%959.26M
15.87%586.25M
22.16%363.21M
38.63%166.6M
20.72%781.12M
38.27%505.94M
14.61%297.32M
Operating cost
-4.71%60.75M
-1.62%40.45M
-27.99%12.93M
9.68%102.15M
-4.57%63.76M
2.43%41.12M
15.80%17.96M
11.21%93.13M
30.08%66.82M
14.12%40.14M
Operating tax surcharges
12.12%6.62M
17.39%5.26M
26.47%1.43M
18.61%9.76M
2.94%5.9M
9.20%4.48M
0.94%1.13M
15.33%8.23M
39.12%5.73M
28.05%4.1M
Operating expense
26.89%342.93M
18.24%207.05M
-8.28%71.89M
15.73%495.44M
4.95%270.26M
14.18%175.11M
14.13%78.39M
3.89%428.12M
18.06%257.51M
-0.83%153.37M
Administration expense
22.44%81.13M
33.72%54.11M
12.59%24.97M
29.22%106.82M
14.31%66.26M
2.19%40.46M
15.89%22.18M
-4.27%82.66M
-7.83%57.96M
-9.85%39.6M
Financial expense
-13.14%-6.63M
-59.14%-6M
-28.00%-2.2M
27.55%-7.95M
40.27%-5.86M
53.37%-3.77M
67.47%-1.72M
48.11%-10.97M
39.97%-9.82M
32.38%-8.08M
-Interest expense (Financial expense)
12.04%3.97M
13.30%2.67M
37.51%1.41M
50.71%4.81M
76.90%3.54M
184.89%2.36M
1,441.19%1.02M
4,286.84%3.19M
3,316.43%2M
1,816.19%826.91K
-Interest Income (Financial expense)
1.76%-9.08M
-17.00%-6.94M
-24.89%-3.46M
11.68%-12.59M
22.04%-9.24M
34.03%-5.93M
48.46%-2.77M
33.01%-14.26M
28.01%-11.86M
25.34%-9M
Research and development
-50.30%92.41M
-39.02%64.53M
-46.92%25.83M
40.62%253.03M
45.56%185.93M
55.17%105.81M
131.58%48.66M
128.13%179.94M
179.06%127.73M
98.05%68.19M
Credit Impairment Loss
-60.63%-11.69M
-117.30%-22.07M
26.98%-5.56M
72.19%-9.84M
63.68%-7.28M
44.77%-10.16M
-116.24%-7.61M
-317.30%-35.37M
-218.59%-20.03M
-363.16%-18.39M
Asset Impairment Loss
-210.47%-1.43M
129.91%139.17K
151.32%94.42K
81.27%-1.63M
236.90%1.29M
46.41%-465.23K
71.78%-183.96K
-345.37%-8.71M
-3.45%-944.55K
-46.55%-868.06K
Other net revenue
-535.12%-20.53M
-452.04%-24.28M
-178.90%-4.36M
-308.64%-41.52M
102.28%4.72M
948.03%6.9M
-42.30%5.52M
-92.64%19.9M
-99.02%2.33M
-113.25%-813.22K
Fair value change income
-173.17%-8.01M
-129.64%-4.58M
-96.00%521.7K
-160.89%-31.6M
-6.44%10.94M
62.00%15.44M
4.10%13.05M
-80.73%51.89M
-95.09%11.7M
24.75%9.53M
Invest income
--957.51K
--800.42K
--91.66K
-93.04%348.75K
----
----
----
7.68%5.01M
23.35%5.01M
77.93%5.01M
Asset deal income
---1.79M
----
----
---186.83K
----
----
----
----
----
----
Other revenue
687.23%1.43M
-31.00%1.43M
88.31%491.51K
-80.51%1.38M
-103.70%-244.09K
-46.85%2.08M
-78.27%261.01K
3.91%7.08M
248.06%6.6M
1,487.07%3.91M
Operating profit
13.25%462.65M
26.35%351.41M
47.09%172.15M
-15.88%576.61M
-25.85%408.53M
-23.09%278.12M
-25.04%117.04M
-25.14%685.5M
-15.36%550.94M
21.07%361.64M
Add:Non operating Income
-99.96%15.85
----
----
-87.34%15.5K
-63.85%44.07K
208.45%15.43K
729,894.63%10.88K
-70.91%122.45K
-71.04%121.92K
109.06%5K
Less:Non operating expense
-60.27%214.17K
-53.95%111.46K
-93.32%10.68K
43.83%2.63M
-54.49%539.07K
-78.56%242.03K
98,293.32%159.84K
205.41%1.83M
106.53%1.18M
134.82%1.13M
Total profit
13.33%462.44M
26.42%351.3M
47.27%172.14M
-16.06%573.99M
-25.80%408.03M
-22.92%277.9M
-25.14%116.89M
-25.32%683.79M
-15.50%549.87M
20.89%360.52M
Less:Income tax cost
44.62%56.53M
50.71%44.75M
93.85%22.68M
-24.44%64.78M
-41.27%39.09M
-33.79%29.69M
-43.91%11.7M
-0.43%85.73M
-1.24%66.56M
-2.63%44.84M
Net profit
10.02%405.9M
23.51%306.55M
42.09%149.47M
-14.86%509.22M
-23.66%368.94M
-21.37%248.2M
-22.24%105.19M
-27.90%598.07M
-17.15%483.31M
25.18%315.68M
Net profit from continuing operation
10.02%405.9M
----
42.09%149.47M
-14.86%509.22M
-23.66%368.94M
----
-22.24%105.19M
-27.90%598.07M
-17.15%483.31M
----
Net profit of parent company owners
10.02%405.9M
23.51%306.55M
42.09%149.47M
-14.86%509.22M
-23.66%368.94M
-21.37%248.2M
-22.24%105.19M
-27.90%598.07M
-17.15%483.31M
25.18%315.68M
Earning per share
Basic earning per share
11.29%3.0697
24.20%2.3049
42.45%1.1204
-14.73%3.8073
-23.52%2.7584
-21.17%1.8558
-21.94%0.7865
-27.56%4.4652
-16.79%3.6067
25.65%2.3542
Diluted earning per share
11.30%3.0697
24.23%2.3049
42.49%1.1204
-14.71%3.8073
-23.53%2.758
-21.19%1.8554
-21.96%0.7863
-27.57%4.464
-16.79%3.6067
25.65%2.3542
Other composite income
Total composite income
10.02%405.9M
23.51%306.55M
42.09%149.47M
-14.86%509.22M
-23.66%368.94M
-21.37%248.2M
-22.24%105.19M
-27.90%598.07M
-17.15%483.31M
25.18%315.68M
Total composite income of parent company owners
10.02%405.9M
23.51%306.55M
42.09%149.47M
-14.86%509.22M
-23.66%368.94M
-21.37%248.2M
-22.24%105.19M
-27.90%598.07M
-17.15%483.31M
25.18%315.68M
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
--
--
Unqualified opinion
--
--
--
Unqualified opinion
--
--
Auditor
--
--
--
Lixin Certified Public Accountants (Special General Partnership)
--
--
--
Lixin Certified Public Accountants (Special General Partnership)
--
--
(Q9)Sep 30, 2024(Q6)Jun 30, 2024(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022
Total operating revenue 7.10%1.06B16.81%741.08M11.96%311.37M9.03%1.58B-6.12%990.06M-3.84%634.44M4.27%278.11M11.94%1.45B35.23%1.05B19.53%659.77M
Operating revenue 7.10%1.06B16.81%741.08M11.96%311.37M9.03%1.58B-6.12%990.06M-3.84%634.44M4.27%278.11M11.94%1.45B35.23%1.05B19.53%659.77M
Other operating revenue ----3,747,465.37%106.24M-----99.11%2.84K------2.84K------318.58K------0
Total operating cost -1.54%577.2M0.60%365.39M-19.05%134.86M22.80%959.26M15.87%586.25M22.16%363.21M38.63%166.6M20.72%781.12M38.27%505.94M14.61%297.32M
Operating cost -4.71%60.75M-1.62%40.45M-27.99%12.93M9.68%102.15M-4.57%63.76M2.43%41.12M15.80%17.96M11.21%93.13M30.08%66.82M14.12%40.14M
Operating tax surcharges 12.12%6.62M17.39%5.26M26.47%1.43M18.61%9.76M2.94%5.9M9.20%4.48M0.94%1.13M15.33%8.23M39.12%5.73M28.05%4.1M
Operating expense 26.89%342.93M18.24%207.05M-8.28%71.89M15.73%495.44M4.95%270.26M14.18%175.11M14.13%78.39M3.89%428.12M18.06%257.51M-0.83%153.37M
Administration expense 22.44%81.13M33.72%54.11M12.59%24.97M29.22%106.82M14.31%66.26M2.19%40.46M15.89%22.18M-4.27%82.66M-7.83%57.96M-9.85%39.6M
Financial expense -13.14%-6.63M-59.14%-6M-28.00%-2.2M27.55%-7.95M40.27%-5.86M53.37%-3.77M67.47%-1.72M48.11%-10.97M39.97%-9.82M32.38%-8.08M
-Interest expense (Financial expense) 12.04%3.97M13.30%2.67M37.51%1.41M50.71%4.81M76.90%3.54M184.89%2.36M1,441.19%1.02M4,286.84%3.19M3,316.43%2M1,816.19%826.91K
-Interest Income (Financial expense) 1.76%-9.08M-17.00%-6.94M-24.89%-3.46M11.68%-12.59M22.04%-9.24M34.03%-5.93M48.46%-2.77M33.01%-14.26M28.01%-11.86M25.34%-9M
Research and development -50.30%92.41M-39.02%64.53M-46.92%25.83M40.62%253.03M45.56%185.93M55.17%105.81M131.58%48.66M128.13%179.94M179.06%127.73M98.05%68.19M
Credit Impairment Loss -60.63%-11.69M-117.30%-22.07M26.98%-5.56M72.19%-9.84M63.68%-7.28M44.77%-10.16M-116.24%-7.61M-317.30%-35.37M-218.59%-20.03M-363.16%-18.39M
Asset Impairment Loss -210.47%-1.43M129.91%139.17K151.32%94.42K81.27%-1.63M236.90%1.29M46.41%-465.23K71.78%-183.96K-345.37%-8.71M-3.45%-944.55K-46.55%-868.06K
Other net revenue -535.12%-20.53M-452.04%-24.28M-178.90%-4.36M-308.64%-41.52M102.28%4.72M948.03%6.9M-42.30%5.52M-92.64%19.9M-99.02%2.33M-113.25%-813.22K
Fair value change income -173.17%-8.01M-129.64%-4.58M-96.00%521.7K-160.89%-31.6M-6.44%10.94M62.00%15.44M4.10%13.05M-80.73%51.89M-95.09%11.7M24.75%9.53M
Invest income --957.51K--800.42K--91.66K-93.04%348.75K------------7.68%5.01M23.35%5.01M77.93%5.01M
Asset deal income ---1.79M-----------186.83K------------------------
Other revenue 687.23%1.43M-31.00%1.43M88.31%491.51K-80.51%1.38M-103.70%-244.09K-46.85%2.08M-78.27%261.01K3.91%7.08M248.06%6.6M1,487.07%3.91M
Operating profit 13.25%462.65M26.35%351.41M47.09%172.15M-15.88%576.61M-25.85%408.53M-23.09%278.12M-25.04%117.04M-25.14%685.5M-15.36%550.94M21.07%361.64M
Add:Non operating Income -99.96%15.85---------87.34%15.5K-63.85%44.07K208.45%15.43K729,894.63%10.88K-70.91%122.45K-71.04%121.92K109.06%5K
Less:Non operating expense -60.27%214.17K-53.95%111.46K-93.32%10.68K43.83%2.63M-54.49%539.07K-78.56%242.03K98,293.32%159.84K205.41%1.83M106.53%1.18M134.82%1.13M
Total profit 13.33%462.44M26.42%351.3M47.27%172.14M-16.06%573.99M-25.80%408.03M-22.92%277.9M-25.14%116.89M-25.32%683.79M-15.50%549.87M20.89%360.52M
Less:Income tax cost 44.62%56.53M50.71%44.75M93.85%22.68M-24.44%64.78M-41.27%39.09M-33.79%29.69M-43.91%11.7M-0.43%85.73M-1.24%66.56M-2.63%44.84M
Net profit 10.02%405.9M23.51%306.55M42.09%149.47M-14.86%509.22M-23.66%368.94M-21.37%248.2M-22.24%105.19M-27.90%598.07M-17.15%483.31M25.18%315.68M
Net profit from continuing operation 10.02%405.9M----42.09%149.47M-14.86%509.22M-23.66%368.94M-----22.24%105.19M-27.90%598.07M-17.15%483.31M----
Net profit of parent company owners 10.02%405.9M23.51%306.55M42.09%149.47M-14.86%509.22M-23.66%368.94M-21.37%248.2M-22.24%105.19M-27.90%598.07M-17.15%483.31M25.18%315.68M
Earning per share
Basic earning per share 11.29%3.069724.20%2.304942.45%1.1204-14.73%3.8073-23.52%2.7584-21.17%1.8558-21.94%0.7865-27.56%4.4652-16.79%3.606725.65%2.3542
Diluted earning per share 11.30%3.069724.23%2.304942.49%1.1204-14.71%3.8073-23.53%2.758-21.19%1.8554-21.96%0.7863-27.57%4.464-16.79%3.606725.65%2.3542
Other composite income
Total composite income 10.02%405.9M23.51%306.55M42.09%149.47M-14.86%509.22M-23.66%368.94M-21.37%248.2M-22.24%105.19M-27.90%598.07M-17.15%483.31M25.18%315.68M
Total composite income of parent company owners 10.02%405.9M23.51%306.55M42.09%149.47M-14.86%509.22M-23.66%368.94M-21.37%248.2M-22.24%105.19M-27.90%598.07M-17.15%483.31M25.18%315.68M
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions ------Unqualified opinion------Unqualified opinion----
Auditor ------Lixin Certified Public Accountants (Special General Partnership)------Lixin Certified Public Accountants (Special General Partnership)----

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Heat List
CN
Overall
Symbol
Price
% Chg

No Data

Investment Theme Virus Prevention
Virus Prevention
Intraday-0.69%
Biological Vaccine
Biological Vaccine
Intraday-0.85%
Transferring Securities of Securities
Transferring Securities of Securities
Intraday-1.58%